← Open Payments lookup

NAEEM AFTAB: Open Payments

NPI 1679668719 · GENEVA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,227 in 15 payments from 10 companies in 2025. Trend: 2023 $2,194 · 2024 $1,278 · 2025 $1,227

Food & beverage: $1,227
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.3$242
Alkermes, Inc.2$152
Supernus Pharmaceuticals, Inc.2$127
Janssen Pharmaceuticals, Inc1$125
Axsome Therapeutics, Inc.1$125
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$124
ABBVIE INC.1$115
E.R. Squibb & Sons, L.L.C.1$106
Otsuka America Pharmaceutical, Inc.2$92
Tris Pharma Inc1$19

Products named: LYBALVI, Qelbree, AUSTEDO XR, INVEGA SUSTENNA, Auvelity, CAPLYTA, UZEDY, VRAYLAR.

Industry payments across NY — which companies pay providers there.